NSV Partners III LP, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 200,000 shares at $30.31 ($6.0M) on 2023-04-13, disclosed to the SEC on 2023-04-14.
Scheduled sale ($6.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.01 | 28,554 | $857K | 14.2% |
| 2 | $30.01 | 28,554 | $857K | 14.2% |
| 3 | $30.31 | 71,446 | $2.2M | 35.8% |
| 4 | $30.31 | 71,446 | $2.2M | 35.8% |
| Total | $30.22 avg | 200,000 | $6.0M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-19 | $7.0M | — | Filing → |
| VTYX | SELL | 2023-07-06 | $10.5M | — | Filing → |
| VTYX | SELL | 2023-06-16 | $1.8M | — | Filing → |